Biotech RadarJobs updated

COMPANY

Entegrion

entegrion.com ↗

FDA-cleared device company Past trials only

Profile checked Oct 10, 2026

Keywords: Coagulopathy Hemostasis Monitoring Coagulation Coagulation Defects FP24 (Frozen Plasma)

4Trials (company is sponsor)

Timeline

  1. Trial start Phase 2: Comparison of the Efficacy & Safety of Resusix With FP24 in Patients With Acquired Coagulopathy source ↗
  2. Trial start —: Comparative Analysis of PCM With ROTEM in the Measurement of Viscoelastic Coagulation Parameters source ↗
  3. Trial start —: Reference Range Analysis of the Entegrion Point of Care Coagulation Monitor (PCM™) in Healthy Volunteers source ↗
  4. Trial start Phase 1: Safety Study of Spray-Dried Solvent/Detergent-Treated Plasma for Infusion in Healthy Volunteers source ↗

Clinical trials (lead sponsor) 4

RecordTitlePhaseStatusStartPrimary completion
NCT03700723Comparison of the Efficacy & Safety of Resusix With FP24 in Patients With Acquired CoagulopathyPhase 2TerminatedDec 14, 2018Apr 15, 2020 (actual)
NCT03679286Comparative Analysis of PCM With ROTEM in the Measurement of Viscoelastic Coagulation ParametersNot listedUnknown status (ClinicalTrials.gov)Aug 20, 2018Dec 31, 2020 (estimated)
NCT03133351Reference Range Analysis of the Entegrion Point of Care Coagulation Monitor (PCM™) in Healthy VolunteersNot listedUnknown status (ClinicalTrials.gov)Apr 4, 2017Dec 30, 2020 (estimated)
NCT01589666Safety Study of Spray-Dried Solvent/Detergent-Treated Plasma for Infusion in Healthy VolunteersPhase 1Completed2013-11Sep 9, 2016 (actual)
Feedback